DNLI-H-001

Recruiting

99 years or below

All

Phase N/A

5 participants needed

1 Location

Brief description of study

To investigate the safety and tolerability of multiple doses of DNL593 in participants with FTD-GRN Please refer to section 3 Objectives and Endpoints of the attached protocol. Please refer to section 3 Objectives and Endpoints of the attached protocol.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research
Age: 99 years or below
Gender: All

TBD

Updated on 17 Dec 2024. Study ID: 856890

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Brief description of study

Eligibility of study

Find a site

What happens next?

Interested in the study